Tag: Anti-obesity medications
Anti-obesity Pharmacotherapy: Where Do We Stand in 2023?
by Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Dr. Bays is Medical Director/President, Louisville Metabolic and Atherosclerosis Research Center, and Clinical Associate Professor, University of Louisville School of Medicine in Louisville, Kentucky. Funding: No funding was provided. Disclosures: The author has no conflicts of interest relevant to the content of this article. Bariatric Times. […]
Patient Presentation for Inadequate Weight Loss or Weight Recurrence and Anti-obesity Medications
by Marina Kurian, MD, FACS, FASMBS, DABOM, DABS Dr. Kurian is Director, New York Minimally Invasive Surgery, PLLC, and Clinical Professor of Surgery, NYU Langone Health in New York, New York. Funding: This supplement was sponsored by Medtronic. Disclosures: Dr. Kurian is a speaker for Vivus. Bariatric Times. 2023;20(5–6 Suppl):S10–S11. Key Points Anti-obesity medications (AOMs) […]
Combined Therapies for Obesity: The Dawn of a New Era!
by Adrian G. Dan, MD, FACS, FASMBS Dr. Dan is Medical Director, Weight Management Institute at Summa Health in Akron, Ohio, and Associate Professor of Surgery at Northeastern Ohio Medical University (NEOMED) in Rootstown, Ohio. Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Bariatric Times. […]
A Look Ahead to Obesity Treatment in 2023
by Angela Fitch, MD, FACP, FOMA Dr. Fitch is the President of the Obesity Medicine Association, former Co-Director of the Massachusetts General Hospital Weight Center and an Assistant Professor of Medicine at the Harvard Medical School. She graduated from Iowa State University with a bachelor’s degree in chemical engineering and the University of Cincinnati College of […]
Key Considerations with Newer Anti-obesity Medications
by Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA Dr. Bays is Medical Director, Louisville Metabolic and Atherosclerosis Research Center in Louisville, Kentucky; Chief Science Officer for the Obesity Medicine Association (OMA); and a member of the Board of Trustees of the OMA. Funding: No funding was provided. Disclosures: In the past 12 months, Dr. […]
Anti-obesity Medications: One Strategy to Treat Obesity Patients’ Overall Health
by Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA Dr. Bays is Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center in Louisville, Kentucky. Funding: No funding was provided. Disclosures: The author has no conflicts of interest relevant to the content of this article. Bariatric Times. 2021;18(6):21. Many weight loss programs and […]
